Cambridge Nutritional Sciences (LON:CNSL – Get Free Report) issued its earnings results on Tuesday. The company reported GBX (0.30) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The company had revenue of GBX 236 million during the quarter. Cambridge Nutritional Sciences had a negative net margin of 83.53% and a negative return on equity of 69.62%.
Cambridge Nutritional Sciences Trading Down 3.2%
Shares of LON CNSL traded down GBX 0.05 on Tuesday, reaching GBX 1.50. 1,287,443 shares of the company traded hands, compared to its average volume of 289,956. Cambridge Nutritional Sciences has a fifty-two week low of GBX 1.25 and a fifty-two week high of GBX 2.50. The company has a 50 day moving average of GBX 1.56 and a 200 day moving average of GBX 1.80. The stock has a market capitalization of £3.57 million, a PE ratio of -0.62 and a beta of 1.91.
Cambridge Nutritional Sciences Company Profile
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Featured Stories
- Five stocks we like better than Cambridge Nutritional Sciences
- Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
Receive News & Ratings for Cambridge Nutritional Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Nutritional Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
